Prolactin, levodopa, and immune response in breast cancer.
D000917:Antibody Formation; D001940:Breast / Q000276:immunology; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology*; D002277:Carcinoma / Q000188:drug therapy / Q000276:immunology*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D010906:Pituitary Hormone-Releasing Hormones; D011388:Prolactin / Q000378:metabolism*; D012075:Remission, Spontaneous; D013268:Stimulation, Chemical
D010906:Pituitary Hormone-Releasing Hormones; D004295:Dihydroxyphenylalanine; D011388:Prolactin